A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)

Summary

This study will look at whether this new drug is effective in the treatment of rheumatoid arthritis, and at whether it is safe and well-tolerated by participants with the disease.

Timeline

Start

2005-01

Primary completion

2005-11

Completion

2005-11

Outcome

Missed primary endpoint

registry analysis (superiority or other test); MK-0873 vs Placebo; p = 0.278; Difference in LS Mean 1.48 (95% CI -1.21 to 4.18); ANCOVA NCT00132769 ↗

Drugs

Indications